Medius Holdings Co., Ltd. (3154) AI Stock Analysis

• Market Cap: ¥17.83B
• Dividend Yield: 2.51%
• Average Volume (3M): 18.80K
• Price to Earnings (P/E): 13.0
• Beta (1Y): 0.61
• Revenue Growth: 11.12%
• EPS Growth: 20.58%
• Country: JP
• Employees: 2,517
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.19
• Shares Outstanding: 22,238,216
• 10 Day Avg. Volume: 22,330
• 30 Day Avg. Volume: 18,803
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 67 Neutral
• Price Target: ¥883.00 ▲(10.65% Upside)

Medius Holdings Co., Ltd. shows strong financial performance with revenue growth and profitability improvements, but faces risks from increased leverage and cash flow volatility. The technical analysis indicates a bearish trend, while the valuation suggests the stock may be undervalued. The absence of earnings call and corporate events data limits further insights.

Medius Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and maintenance services for medical equipment to hospitals and other medical facilities. It is also involved in the sale and rental of nursing care and welfare equipment to hospitals, nursing care facilities, and general individuals; and sale and rental of on-board medical instruments for ambulance, AEDs, and other emergency supplies and equipment with high social needs. The company was formerly known as Kyowa Medical Holdings, Inc. and changed its name to Medius Holdings Co., Ltd. in October 2010. Medius Holdings Co., Ltd. was founded in 2009 and is based in Tokyo, Japan.

How the Company Makes Money

Medius Holdings generates revenue through a combination of software licensing, subscription services, and consulting fees associated with its healthcare technology solutions. The company typically charges clients for initial software licenses, followed by recurring revenue from annual maintenance and subscriptions for ongoing access to their platforms. Additionally, Medius Holdings engages in strategic partnerships with healthcare providers and institutions, allowing them to expand their market reach and enhance their product offerings. These partnerships often lead to joint ventures or collaborative projects that further contribute to the company's earnings.

Medius Holdings Co., Ltd. Financial Statement Overview

Summary

Medius Holdings Co., Ltd. demonstrates strong revenue growth and stable profitability margins. The balance sheet is solid with adequate leverage, though cash flow variations require attention.

Income Statement

Medius Holdings Co., Ltd. shows a strong revenue growth trajectory with recent TTM data indicating a rise in total revenue. The gross profit margin is stable, reflecting efficient cost management. However, the net profit margin has shown some volatility, which could be a concern. EBIT and EBITDA margins are consistent, suggesting operational stability.

Balance Sheet

The company's balance sheet reveals a moderate debt-to-equity ratio, indicating a balanced approach to leverage. The return on equity is healthy, demonstrating effective utilization of shareholder funds. The equity ratio is satisfactory, reflecting a solid asset base supported by equity.

Cash Flow

Cash flow analysis shows fluctuations in free cash flow, influenced by capital expenditure dynamics. Despite operating cash flow being zero in the latest TTM data, previous periods have shown positive cash flow generation. The company needs to focus on sustaining free cash flow for long-term stability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	286.18B	288.69B	259.79B	239.05B	221.69B	246.79B
Gross Profit	33.60B	33.30B	31.09B	29.31B	27.42B	25.20B
EBITDA	4.44B	4.77B	3.86B	4.27B	3.80B	4.14B
Net Income	1.35B	1.38B	1.12B	1.50B	1.87B	2.07B
Balance Sheet
Total Assets	123.52B	113.02B	114.83B	97.46B	92.95B	84.44B
Cash, Cash Equivalents and Short-Term Investments	16.13B	14.33B	13.66B	10.36B	9.15B	12.67B
Total Debt	24.26B	21.24B	24.17B	19.57B	17.82B	11.60B
Total Liabilities	102.87B	92.55B	95.09B	78.88B	75.65B	68.59B
Stockholders Equity	20.65B	20.48B	19.74B	18.57B	17.31B	15.84B
Cash Flow
Free Cash Flow	0.00	5.26B	261.12M	300.65M	-8.49B	2.93B
Operating Cash Flow	0.00	7.01B	1.92B	1.22B	-3.90B	6.85B
Investing Cash Flow	0.00	-2.51B	-2.67B	-862.94M	-4.82B	-4.62B
Financing Cash Flow	0.00	-3.47B	4.01B	862.90M	5.21B	1.90B

Medius Holdings Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 798.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Negative. The current price of 798 is below the 20-day moving average (MA) of 820.40, below the 50-day MA of 837.60, and below the 200-day MA of 882.30, indicating a bearish trend. The MACD of -8.97 indicates Positive momentum. The RSI at 36.25 is Neutral, neither overbought nor oversold. The STOCH value of 9.18 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3154.

Medius Holdings Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7980	―	¥5.62B	8.44	―	1.87%	5.45%	0.23%
4556	―	¥4.99B	8.58	―	2.63%	3.14%	-2.85%
7979	―	¥67.62B	16.63	―	2.79%	6.82%	-1.08%
3154	―	¥17.83B	12.95	―	2.51%	11.12%	20.58%
7743	―	¥17.19B	15.42	―	2.64%	2.38%	-48.68%
7702	―	¥10.51B	―	―	3.95%	3.36%	-310.49%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Medius Holdings Co., Ltd. Corporate Events

Medius Holdings Completes Strategic Merger to Strengthen Hokkaido Presence

Medius Holdings Co., Ltd. has completed an absorption-type merger involving its subsidiaries, Active Medical Co., Ltd. and NOAH INTERNATIONAL Co., Ltd., resulting in the formation of A. North Medical Inc. This strategic move is intended to consolidate management resources and enhance sales capabilities, aiming to expand market share in Hokkaido’s medical equipment sector. The merger is expected to generate synergies and improve service to medical institutions, although its financial impact on the company’s consolidated results is anticipated to be minor.

The most recent analyst rating on (JP:3154) stock is a Buy with a Yen933.00 price target. To see the full list of analyst forecasts on Medius Holdings Co., Ltd. stock, see the JP:3154 Stock Forecast page.

Medius Holdings Proposes Amendments to Articles of Incorporation

Medius Holdings Co., Ltd. has announced a proposal to amend its Articles of Incorporation to better align with its current business activities. The proposed changes, which will be presented at the upcoming General Meeting of Shareholders, include the addition of new business objectives such as transportation, warehousing, and staffing services, indicating a strategic expansion into these areas.

The most recent analyst rating on (JP:3154) stock is a Hold with a Yen937.00 price target. To see the full list of analyst forecasts on Medius Holdings Co., Ltd. stock, see the JP:3154 Stock Forecast page.

Medius Holdings Co., Ltd. Reports Increased Profitability and New Three-Year Plan

Medius Holdings Co., Ltd. reported an increase in net sales and gross profit for the fiscal year ended June 30, 2025, driven by more surgical operations, new customer acquisitions, and expanded sales from previously acquired or spun-off companies. Despite rising costs due to high energy prices and exchange rate fluctuations, the company has largely achieved its Medium-Term Business Plan targets ahead of schedule and announced a new three-year plan through to FYE 6/2028. The company aims to sustain growth and enhance shareholder returns while contributing to regional medical care.

Medius Holdings Exceeds Financial Forecasts and Increases Dividend

Medius Holdings Co., Ltd. announced that its actual financial results for the fiscal year ending June 30, 2025, surpassed its previous forecasts, with net sales and profits exceeding expectations due to strong product sales and cost efficiencies. Additionally, the company declared a dividend increase, aligning with its policy to maintain a dividend payout ratio of 30% or more, reflecting its commitment to shareholder returns and sustainable growth.